Evaluation of vascular cell adhesion molecule-1 (VCAM-1) level changes in patients with lymphoproliferative diseases during antitumor therapy

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Emerging insights in cardio-oncology: biomarkers, cardiotoxicity, and protective therapies Cardio-Oncology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by